Nigeria, March 2 -- Nigeria will receive consignments of Lenacapavir, a new twice-yearly injectable drug for HIV prevention in March 2026, marking a major step in the country's efforts to curb new infections.

The National Agency for the Control of AIDS (NACA) confirmed the development on Monday in a statement signed by its Head of Public Relations and Protocol, by Toyin Aderibigbe.

NACA said the federal government is advancing preparations for the introduction and rollout of Lenacapavir as pre-exposure prophylaxis (PrEP).

The agency said the move is part of the government's commitment to strengthen HIV prevention and accelerate progress towards epidemic control.

According to the statement, commodities are expected in the country in Ma...